Home > Drug Search >
  • company_query: Alfasigma
  •   > 
Drug Filter
Category:
chemistry (11) biology (24)
Status:
Approved (1) Withdrawn (1) BLA Filing (2) Phase Ⅲ (4) Phase Ⅱ (12) Phase Ⅰ (14)
Clinical Stage:
Pending (4) Active (24) Discontinued (5)
Bio-Type:
Gene therapy (2) Cell therapy (2) Vaccine (16) Recombinant polypeptide (1) Recombinant hormone (1) Whole antibody (1)
Indication:
Acute myeloid Leukemia (AML) (1) Bladder cancer (1) Constipation (1) Avian influenza (2) Rheumatic disorders (1) Transplant rejection (1) Glaucoma (1) Cytomegalovirus infections (1) HCV infection (1) Inflammatory bowel disease (1) Influenza virus infection (6) Melanoma (2) Non small cell lung cancer (NSCLC) (1) Osteoporosis (1) Pancreatic cancer (1) Parkinson's disease (PD) (1) Postoperative pain (1) Haemophilus infection (1) Prostate cancer (2) Middle East respiratory syndrome coronavirus (1) Zika virus infection (1) Rectal fistula (1) Solid tumours (1) Ulcerative colitis (1) Cirrhosis (1) Acute enterocolitis (1) Chronic heart failure (1) Pain (1) Anaplastic astrocytoma (1) Contraception (1) Portal hypertension (1) Acute heart failure (1) Glioblastoma (2) Gingival diseases (1) Coronary heart disease (1) Respiratory syncytial virus infection (1) Mesothelioma (1) Neurological disease (1) Ebola virus disease (EVD) (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top